Ribosomes Team Up to Translate Tricky mRNA Segments

During translation, ribosomes can pause on the nucleic acid. Researchers showed that collisions from incoming proteins get them moving again.

Written byShelby Bradford, PhD
| 3 min read
3D illustration of blue and yellow ribosomes translating red mRNA into purple polypeptides.
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

During translation, multiple ribosomes travel along the nucleic acid chain to build polypeptides that become functional proteins. Occasionally, these molecular decoders pause on the mRNA, either because they are instructed to do so or they have difficulty traversing the sequence. Previous studies that investigated these events looked at isolated ribosomal proteins as opposed to the multiple ribosomes typically involved in translation, leaving questions about how these pauses affect translation and how they are overcome.1

To elucidate this process, a team led by Marvin Tanenbaum, a molecular biologist studying single-molecule dynamics at Hubrecht Institute, developed a novel imaging method to study ribosome dynamics. In a study published in Cell, Tanenbaum and his team demonstrated that ribosomes use collisions to move past pause sites and other complicated segments of mRNA to increase translation efficiency.2 These findings introduce a new mechanism in translation and polypeptide formation.

First, the researchers generated stopless-ORF circular RNAs (socRNAs) that promoted continuous translation for extended periods of time. The researchers visualized translation, including ribosome pauses, by using the intensity of GFP-tagged antibodies on the polypeptide to measure polypeptide elongation.

As Tanenbaum and his team watched translation unfold, they found that at any given time, each socRNA was bound by one to four ribosomes and that these molecular machines exhibited varied translation speeds. With the help of computational models, the researchers demonstrated how faster incoming ribosomes “bump into” the stalled-out ribosomes. These collisions occurred rapidly even when there were as few as two ribosomes on the socRNA.

Previous studies showed that when the leading protein stalls, the ribosome collisions that occur trigger the removal of the affected ribosomes.3,4 However, Tanenbaum’s team didn’t see this occurring in their experiments. They estimated that the collisions that they observed lasted between a few milliseconds to seconds, so they set out to determine whether the length of time a collision lasts influences its outcome.

Continue reading below...

Like this story? Sign up for FREE Cell Biology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

Using a socRNA that included a pause site and another with a mutation that caused a longer pause period, the team determined that the mutant construct caused more collisions that lasted longer. Additionally, compared to the control socRNA, the number of ribosomes on the mutant socRNA decreased over time, suggesting an increase in degradation.

Since these brief collisions did not induce translation termination and ribosome disassembly, the researchers explored other ways that these encounters influenced ribosome activity. They found that when a sequence included a pause site, translation occurred faster if there were two ribosomes translating the socRNA compared to just one. This effect, which they termed ribosome cooperativity, extended to delays in other difficult mRNA regions, such as translation through repetitive sequences and complicated RNA structures.

“This allows ribosomes to endure short collisions on problematic RNA sections, thereby promoting continuous protein production”, Maximilian Madern, a PhD student in Tanenbaum’s group at Hubrecht Institute and study coauthor, said in a statement.

Lastly, the team evaluated the effect of ribosome cooperativity on socRNA sequences that did not include specific pause sequences or problematic patterns. Whereas translation with a single ribosome led to extended pauses in about five percent of the translation runs, sequences translated with two or more ribosomes experienced reduced pausing.

These findings support a new mechanism in maintaining translation efficiency and help elucidate the process of ribosome recycling.

  1. Behrmann E, et al. Structural snapshots of actively translating human ribosomes. Cell. 2015;161(4):845-857.
  2. Madern MF, et al. Long-term imaging of individual ribosomes reveals ribosome cooperativity in mRNA translation. Cell. 2025.
  3. Simms CL, et al. Ribosome collision is critical for quality control during no-go decay. Mol Cell. 2017;68(2):361-373.E5.
  4. Juszkiewicz S, et al. ZNF598 is a quality control sensor of collided ribosomes. Mol Cell. 2018;72(3):469-481.E7.

Related Topics

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Assistant Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform